From educated guess to accepted practice: The use of oral antidiabetic agents in pregnancy

Clinical Obstetrics and Gynecology

Volumn 50, Issue 4, 2007, Pages 959-971

  Langer, Oded ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Gestational diabetes; Glyburide; Level of glycemic control; Perinatal outcome

Indexed keywords

ACARBOSE; CHLORPROPAMIDE; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; MIGLITOL; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SITAGLIPTIN; VOGLIBOSE;

ALGORITHM; ARTICLE; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG MILK LEVEL; DRUG USE; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; GLUCOSE HOMEOSTASIS; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LACTIC ACIDOSIS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY DIABETES MELLITUS; RHINOPHARYNGITIS; SIDE EFFECT; TERATOGENICITY; TREATMENT PLANNING; WEIGHT GAIN;

ADMINISTRATION, ORAL; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; HUMANS; HYPOGLYCEMIC AGENTS; PREGNANCY; PREGNANCY OUTCOME; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 35848965693     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31815a55f3     Document Type: Article

References (11)

1. Langer O, Conway DL, Berkus MD, et al. A comparison glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343:1134-1138.
2. Greene MF. Oral hypoglycemic drugs for gestational diabetes [editorial]. N Engl J Med. 2000;343:1178-1179.
3. Saade G. Gestational diabetes mellitus: a pill or a shot? [editorial]. Obstet Gynecol. 2005;105:456-457.
4. Yogev Y, Ben-Haroush A, Chen R, et al. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol. 2004;104:88-93.
5. Kraemer J, Klein J, Lubetsky A, et al. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. Am J Obstet Gynecol. 2006;195:270-274.
6. Glueck CJ, Wang P, Kobayashi S, et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril. 2002;77:520-525.
7. Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol. 2004;190:1438-1439.
8. Kahn BF, Davies JK, Lynch AM, et al. Predictors of glyburide failure in the treatment of gestational diabetes. Obstet Gynecol. 2006;107:1303-1309.
9. Jacobson GF, Ramos G, Ching J, et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol. 2005;193:118-124.
10. Langer O, Most O, Monga S. Glyburide: predictors of treatment failure in gestational diabetes [abstract]. Am J Obstet Gynecol. 2006;195:S136.
11. Langer O, Yogev Y, Xenakis E, et al. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol. 2005;192:134-139.